Key facts
- This page summarizes Joseph H. Wender's Form 4 filing for IONIS PHARMACEUTICALS INC (IONS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 20 Nov 2025, 17:12.
Joseph H. Wender - 18 Nov 2025 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)
- Reporting relationship
- Director
- Issuer ticker
- IONS
- Reported as of
- 18 Nov 2025
- Net transaction value
- +$390,720
- SEC form
- 4
- Accepted by SEC
- 20 Nov 2025, 17:12:23 UTC
- Prior SEC filing
- 03 Nov 2025
- Next SEC filing
- 03 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- By: Patrick R. O'Neil, attorney-in-fact For: Joseph H. Wender
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Joseph H. Wender filed Form 4 for IONIS PHARMACEUTICALS INC (IONS) on 20 Nov 2025.
Change
- Previous filing in this sequence was filed on 03 Nov 2025.
- Current net transaction value: +$390,720.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001073384
Primary reporting owner
WENDER JOSEPH H
- Relationship
- Director
- Address
- 2855 GAZELLE COURT, CARLSBAD
- Signature
- By: Patrick R. O'Neil, attorney-in-fact For: Joseph H. Wender
- Signature date
- 19 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IONS
transaction
Common Stock
Options Exercise
- Transaction value
- $390,720
- Shares
- +16,000
- Change %
- Price
- $24.42
- Shares after
- 16,000
- Date
- 18 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
IONS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 64,035
- Date
- 18 Nov 2025
- Ownership
- by Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IONS
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -16,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,000
- Exercise price
- $24.42
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Acquired as a result of exercising a stock option that was scheduled to expire on 6/30/2026.